PRICE T ROWE ASSOCIATES INC /MD/
Position in DSGN — Design Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in DSGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$370,518
+$196,342 QoQ
Shares Held
25,606
+56.4% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 136 holders
Holding Since
Mar 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. DSGN ranks #220 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in DSGN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $370,518 | 25,606 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $174,176 | 16,370 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $147,369 | 15,711 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $122,844 | 16,314 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $54,978 | 16,314 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $50,446 | 13,069 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $76,822 | 12,451 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $55,327 | 10,284 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $34,451 | 10,284 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $44,922 | 11,147 | Shares | Defined | 2024-05-15 | |
| 2022-09-30 | $4,683,605 | 280,120 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,943,526 | 353,109 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,270,293 | 574,012 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,863,907 | 787,665 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $21,285,339 | 1,448,968 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $28,819,973 | 1,448,968 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $42,914,094 | 1,435,254 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||